• ABRIDGE-J: Dabigatran lowers bleeding risk in ablation for nonvalvular AF

    One year ago - By Healio

    ANAHEIM, Calif. - Patients with nonvalvular atrial fibrillation who underwent ablation and were treated with minimally disrupted dabigatran with and without heparin had a decreased risk for bleeding complications and no increase in thromboembolic events compared with those treated with warfarin, according to data presented at the American Heart Association Scientific Sessions.
    Akihiko Nogami, MD, PhD, of the University of Tsukuba in Japan, and colleagues assessed data from 500 patients with persistent or paroxysmal nonvalvular AF who were scheduled for initial catheter ablation. Patients
    Read more ...